Modulation of the Tumor Suppressor Protein PP2A Using a Small Molecule Agonist Overcomes Multi-Drug Resistance through Mitochondrial Permeability Transition Pore (MPTP) Dependent Induction of Apoptosis in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Jayappa, Kallesh D.
Farrington, Caroline
Gordon, Vicki L.
Saha, Shekhar
Morris, Christopher
Isaac, Krista M.
Bender, Timothy P.
Williams, Michael E.
Portell, Craig A.
Narla, Goutham
Weber, Michael J.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 2 条
  • [1] PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
    Jayappa, Kallesh D.
    Tran, Brian
    Gordon, Vicki L.
    Morris, Christopher
    Saha, Shekhar
    Farrington, Caroline C.
    O'Connor, Caitlin M.
    Zawacki, Kaitlin P.
    Isaac, Krista M.
    Kester, Mark
    Bender, Timothy P.
    Williams, Michael E.
    Portell, Craig A.
    Weber, Michael J.
    Narla, Goutham
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (13):
  • [2] The PP2A activation using a small molecule agonist triggers apoptosis by releasing mitochondrial permeability transition pores in multi-drug resistant leukemic B cells.
    Jayappa, Kallesh D.
    Farrington, Caroline
    Gordon, Vicki L.
    Saha, Shekhar
    Morris, Christopher
    Isaac, Krista M.
    Bender, Timothy P.
    Williams, Michael E.
    Portell, Craig A.
    Narla, Goutham
    Weber, Michael J.
    CANCER RESEARCH, 2021, 81 (13)
1